George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDukemount Capi. Regulatory News (DKE)

Share Price Information for Dukemount Capi. (DKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.031
Bid: 0.027
Ask: 0.035
Change: 0.00 (0.00%)
Spread: 0.008 (29.63%)
Open: 0.031
High: 0.031
Low: 0.031
Prev. Close: 0.031
DKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

16 Jun 2023 07:00

RNS Number : 8793C
Dukemount Capital PLC
16 June 2023
 

Dukemount Capital Plc

("Dukemount" or "the Company")

 

Interim Results for the six months ended 31 October 2022

 

Dukemount Capital Plc (LSE: DKE) is pleased to announce its unaudited interim results for the six months ended 31 October 2022 ("the Interim Report").

 

For further information, please visit www.dukemountcapitalplc.com or contact:

 

Dukemount Capital Plc : Email info@dukemountplc.com

CEO: Paul Gazzard

Non-Exec Director Geoffery Dart

 

Broker Enquiries:

Peterhouse Capital Limited Tel: +44 (0) 207 469 0930

Lucy Williams/Duncan Vasey

 

Summary

 

· Completed sale of two RTB 11kV energy generation sites

· Received further funding and existing funding restructured

 

Operational Developments

 

On 5 October 2022, the Company announced that HSKB Limited ("HSKB"), in which it held a 50% interest, had completed the sale of two special purpose companies containing an 11kV gas peaking facility, ready to build, with full planning permission and grid access for an aggregate sale price of £350,000. The proceeds of the sale have been used to repay a portion of the sums owing to the lenders as detailed in the announcement of 15 September 2021.

 

Further to the disposal of the gas peaking facilities, the lenders agreed to advance net proceeds of £50,000 in aggregate in addition to restructuring their existing funding arrangement. The maturity date for the existing debt plus the further advance is to be 24 months from the date of the Advance (being 10 October 2024). The proceeds of the further advance have been used to settle accrued liabilities of the Company.

 

The board has taken steps to ensure that the financial position and prospects of the Company are maintained to facilitate a future reverse takeover transaction. To that end, the board has confirmed that the directors have released the Company from all accrued but unpaid emoluments; Chesterfield Capital Limited have confirmed that the outstanding balance of £500,000 due to Chesterfield Capital Limited will be converted at a price of 0.65p. Such subscription to settle all balances due from the Company and to be settled by the issuance of shares at the earlier of (a) the approval of a prospectus, (b) the direction of the board of the Company and (c) 31 December 2023.

 

The restructuring and further advance debt is convertible at the nominal value of 0.1p of the ordinary shares of the Company. The further advance is subject to a 5% implementation fee. The Company has settled a 9.5% extension fee of £74,575 to the Noteholders in the form of ordinary shares at the nominal value. Accordingly the Company issued 74,575,000 ordinary shares in the Company on 12 October 2022 and 28,132,190 ordinary shares on 28 October 2022.

 

Paul Gazzard commented:

 

"It has been a tough few months for DKE as we have taken some hard decisions to dispose of assets no longer able to achieve our required regulatory goals. However we look forward to continuing to pursue alternative routes to secure a deal for the Company that can bring value for shareholders. We look forward to updating the market with more developments soon as they are delivered."

Interim Management Report

 

I hereby present the Interim Report for the six months ended 31 October 2022. During the period the Group made a loss of £97,108 (six months to 31 October 2021: loss of £227,218). These losses have been contained in the period to a minimum as the board has taken steps to ensure the financial position and prospects of the Company are maintained to facilitate a future reverse takeover transaction.

 

Outlook

With the support of its funders and professional advisers Dukemount is optimistic a transaction can be secured to further its prospects and deliver value to shareholders. 

I would like to take the opportunity to thank our shareholders for their patience and support and the Dukemount team for their continuing efforts in driving this business forward.

 

Paul Gazzard

On behalf of the Board

 

15th June 2023

 

Responsibility Statement

 

We confirm that to the best of our knowledge:

 

· the Interim Report has been prepared in accordance with International Accounting Standards 34, Interim Financial Reporting, as adopted by the EU;

 

· gives a true and fair view of the assets, liabilities, financial position and loss of the Group;

 

· the Interim Report includes a fair review of the information required by DTR 4.2.7R of the Disclosure and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the set of interim financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

 

· the Interim Report includes a fair review of the information required by DTR 4.2.8R of the Disclosure and Transparency Rules, being the information required on related party transactions.

 

The Interim Report was approved by the Board of Directors and the above responsibility statement was signed on its behalf by:

 

Paul Gazzard

Director

 

15 June 2023

Consolidated Statement of Comprehensive Income

For the six months ended 31 October 2022

 

 

Note

Group

Unaudited

31 Oct 2022

£

Group

Unaudited

31 Oct 2021

£

Group

Audited

30 April 2022

£

Continuing operations

 

 

 

Other operating income

-

-

-

Cost of sales

-

-

-

 

 

 

Gross Profit/(Loss)

-

-

-

 

Other income

-

5,033

Administrative expenses

(97,108)

(227,218)

(185,775)

Impairment of goodwill

-

-

(125,101)

Impairment of receivables

-

-

(578,779)

 

Operating loss

(97,108)

(227,218)

(884,622)

 

Interest received

-

-

-

Finance charges

-

-

(242,773)

 

Loss before taxation

(97,108)

(227,218)

(1,127,395)

 

Income tax

-

-

-

 

Loss for the year attributable to equity owners

(97,108)

(227,218)

(1,127,395)

 

Total comprehensive income for the year attributable to the equity owners

 

(97,108)

(227,218)

(1,127,395)

Total comprehensive income for the year attributable to:

 

Owners of Dukemount Capital Plc

(97,108)

(227,218)

(1,176,088)

Non-controlling interests

-

-

48,693

 

(97,108)

(227,218)

(1,127,395)

 

 

 

Earnings per share attributable to equity owners

 

 

 

Basic and diluted (pence)

4

(0.00019)

(0.00046)

(0.0022)

 

Consolidated Statement of Financial Position

At 31October 2022

 

Note

Group

Unaudited

31 Oct 2022

£

Group

Unaudited

31 Oct 2021

£

Group

Audited

30 April 2022

£

ASSETS

 

 

 

 

 

 

 

Non current assets:

 

 

Intangible assets

-

-

350,000

 

 

-

350,000

Current assets:

 

 

Trade and other receivables

5

17,299

938,836

38,164

Cash and cash equivalents

28,714

40,864

19,214

Total Current assets

 

46,013

979,700

57,378

 

 

 

 

Total assets

46,013

979,700

407,378

 

 

 

LIABILITIES

 

 

 

Current liabilities:

 

 

Trade and other payables

6

1,619,121

1,799,753

1,986,086

 

 

Total Current liabilities

 

1,619,121

1,799,753

1,986,086

 

 

 

Total liabilities

1,619,121

1,799,753

1,986,086

 

 

 

 

NET ASSETS

(1,573,108)

(820,053)

(1,578,708)

 

 

 

Capital and reserve attributable to the equity holders of the Parent

 

 

 

Share capital

616,243

513,535

513,535

Share premium

1,249,305

1,107,783

1,249,305

Share based payments reserve

 

2,960

2,960

2,960

Retained earnings

 

(3,441,616)

(2,444,331)

(3,344,508)

TOTAL EQUITY

 

(1,573,108)

(820,053)

(1,578,708)

 

Consolidated Statement of Changes in Equity

For the six months ended 31 October 2022

 

 

Share capital

Share premium

Share based payment reserve

Retained losses

Total

Non controlling interests

Total equity

 

£

£

£

£

£

 

£

 

Balance as at 1 May 2021

481,283

1,115,035

 2,960

(2,217,113)

(617,835)

-

(617,835)

Loss for the period

-

-

-

(227,218)

(227,218)

-

(227,218)

Total comprehensive income for the period

-

-

-

(227,218)

(227,218)

-

(227,218)

Issue of ordinary shares

32,252

134,270

-

-

166,522

-

166,522

Total transactions with owners

32,252

134,270

-

-

166,522

-

166,522

Balance at 31 October 2021

513,535

1,249,305

2,960

(2,444,331)

(678,531)

-

(678,531)

Loss for the period

-

-

-

(929,543)

(929,543)

29,366

(900,177)

Total comprehensive income for the period

-

-

-

(929,543)

(929,543)

29,366

(900,177)

Issue of ordinary shares

-

-

-

-

-

-

-

Total transactions with owners

-

-

-

-

-

-

-

Balance as at 30 April 2022

513,535

1,249,305

2,960

(3,373,874)

(1,608,074)

29,366

(1,578,708)

Loss for the period

-

-

-

(97,108)

(97,108)

-

(97,108)

Total comprehensive income for the period

-

-

-

(97,108)

(97,108)

-

(97,108)

Issue of ordinary shares

102,708

-

-

-

102,708

-

102,708

Total transactions with owners

102,708

-

-

-

102,708

-

102,708

Balance at 31 October 2022

616,243

1,249,305

2,960

(3,470,982)

(1,602,474)

29,366

(1,573,108)

 

 

Consolidated Statement of Cashflows

For the six months ended 31 October 2022

 

Group

Unaudited

6 months ended

31 Oct 2022

Group

Unaudited

6 months ended

31 Oct 2021

Group

Audited

Year

ended

30 April 2022

£

£

£

Operating activities

 

Loss before taxation

(97,108)

(227,218)

(1,127,395)

Shares issued in lieu of expenses

74,575

-

30,727

Impairment of goodwill

-

-

125,101

Impairment of receivables

-

-

578,779

(Increase)/decrease in trade and other receivables

20,865

(33,214)

(40,627)

(Decrease) / increase in trade and other payables

 

(38,372)

(419,055)

(232,722)

Net cash used in operating activities

40,040

(679,487)

(666,137)

 

 

Cash Flows from Investing Activities

 

 

 

 

Investment in JV

350,000

(329,306)

(339,306)

 

 

Net Cash generated from Investing Activities

350,000

(329,306)

(339,306)

 

 

Cash Flows from Financing Activities

 

 

 

Loans received

50,000

1,000,000

1,000,000

Loans repaid

(350,000)

-

-

Shares issued in lieu of expenses

-

25,000

-

Net Cash generated from Financing Activities

(300,000)

1,025,000

1,000,000

 

 

 

 

Increase/(Decrease) in cash and cash equivalents in period/ year

 

9,960

 

16,207

 

(5,443)

Cash and cash equivalents at beginning of period / year

19,214

24,657

24,657

 

 

 

Cash and cash equivalents at end of period / year

29,174

40,864

19,214

 

Notes to the Interim Report

For the six months ended 31 October 2022

 

1. GENERAL INFORMATION

 

Dukemount Capital Plc (the "Company") is a company domiciled in England. The interim report for the six months ended 31 October 2022 comprises the results of the Company and its subsidiaries (together referred to as the "Group").

 

2. BASIS OF PREPARATION

 

The condensed consolidated interim financial statements have been prepared under the historical cost convention and on a going concern basis and in accordance with International Financial Reporting Standards, International Accounting Standards and IFRIC interpretations endorsed for use in the United Kingdom ("IFRS"). The condensed consolidated interim financial statements contained in this document do not constitute statutory accounts. In the opinion of the directors, the condensed consolidated interim financial statements for this period fairly presents the financial position, result of operations and cash flows for this period. The Board of Directors approved this Interim Financial Report on 15 June 2023.

 

Statement of compliance

 

The Interim Report includes the consolidated interim financial statements which have been prepared in accordance with International Accounting Standard 34 'Interim Financial Reporting'. The condensed interim financial statements should be read in conjunction with the annual financial statements for the period ended 30 April 2022, which have been prepared in accordance with IFRS endorsed for use in the United Kingdom.

 

Accounting policies

 

The condensed consolidated interim financial statements for the period ended 31 October 2021 have not been audited or reviewed in accordance with the International Standard on Review Engagements 2410 issued by the Auditing Practices Board. The figures were prepared using applicable accounting policies and practices consistent with those adopted in the statutory annual financial statements for the year ended 30 April 2022. There have been no new accounting policies adopted since 30 April 2022.

 

Going concern

 

The Group has assessed its ability to continue as a going concern. The Directors, having made due and careful enquiry, are of the opinion that the Group will have access to adequate working capital to meet its obligations for the period of at least twelve months from the date when the condensed interim financial statements are authorised for issue. The Directors therefore have made an informed judgement, at the time of approving these condensed interim financial statements, that there is a reasonable expectation that the Group, having secured agreement with certain creditors, existing investors and its broker on a package of financing measures, has adequate resources to continue in operational existence for the foreseeable future. Going forward, the Group will require further funds. The success of securing these has been identified as a material uncertainty which may cast significant doubt over the going concern assessment. Whilst acknowledging this material uncertainty, based upon the expectation of completing a successful fundraising in the near future, and the continued support of it investors and broker, the Directors consider it appropriate to continue to prepare these condensed interim financial statements for the period ended 31 October 2022 on a going concern basis. 

 

3. RISKS AND UNCERTAINTIES

 

The Board continually assesses and monitors the key risks of the business. The key risks that could affect the Group's short and medium-term performance and the factors that mitigate those risks have not substantially changed from those set out in the Company's 2022 audited financial statements, a copy of which is available on the Company's website: http://www.dukemountcapitalplc.com.

 

4. EARNINGS PER SHARE

 

The basic loss per share is derived by dividing the loss for the period attributable to ordinary shareholders by the weighted average number of shares in issue.

 

Group Unaudited

31 Oct 2022

 

Group Unaudited

31 Oct 2021

 

Group

Audited

30 April 2022

 

£

£

£

Loss for the period

(97,108)

(227,218)

(1,127,395)

Weighted average number of shares - expressed in thousands

521,695

496,352

504,873

Basic earnings per share - expressed in pence

(0.00019)

(0.00046)

(0.0022)

  

5 TRADE AND OTHER RECEIVABLES

 

Group Unaudited

31 Oct 2022

 

Group Unaudited

31 Oct 2021

 

Group

Audited

30 April 2020

 

£

£

£

Trade and other receivables

17,299

377,620

38,164

Amounts recoverable on contracts

-

561,216

-

17,299

938,836

38,164

  

6. TRADE AND OTHER PAYABLES

Group Unaudited

31 Oct 2022

 

Group Unaudited

31 Oct 2021

 

Group

Audited

30April 2022

 

£

£

£

Trade and other payables

721,273

1,681,253

806,296

Other creditors

819,914

-

1,101,250

Accruals

77,934

118,500

78,540

1,619,121

1,799,753

1,986,086

 

7. APPROVAL OF INTERIM FINANCIAL STATEMENTS

The Condensed interim financial statements were approved by the Board of Directors on 12 June 2023. A copy can be obtained on the Company's website at www.dukemountcapitalplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR SFLFFIEDSEDM
Date   Source Headline
18th Apr 20243:09 pmRNSResult of AGM
21st Mar 20247:00 amRNSNotice of AGM and a conditional subscription
8th Mar 20244:29 pmRNSTR-1: Standard form notification of major holdings
7th Mar 202410:51 amRNSUpdate on the Facility Agreement and TVR
5th Mar 202412:45 pmRNSHolding(s) in Company
4th Mar 20241:16 pmRNSCapitalisation of Loan, Issue of Equity & Warrants
26th Feb 202410:04 amRNSHolding(s) in Company
30th Jan 202412:09 pmRNSFinal Results
12th Jan 20242:13 pmRNSResult of AGM
14th Dec 20239:56 amRNSNotice of AGM
12th Sep 20237:44 amRNSProposed lifting of suspension and other updates
16th Jun 20237:00 amRNSHalf-year Report
9th Jun 202310:17 amRNSFinal Results
22nd Nov 20227:06 amRNSChange of Broker
1st Nov 20228:03 amRNSTemporary Suspension
28th Oct 20224:40 pmRNSSecond Price Monitoring Extn
28th Oct 20224:35 pmRNSPrice Monitoring Extension
28th Oct 20229:32 amRNSIssue of Equity
27th Oct 20224:41 pmRNSSecond Price Monitoring Extn
27th Oct 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20229:32 amRNSIssue of Equity
20th Oct 20229:26 amRNSIssue of Equity
19th Oct 202212:33 pmRNSHolding(s) in Company
19th Oct 20227:00 amRNSHolding(s) in Company
13th Oct 20222:05 pmRNSSecond Price Monitoring Extn
13th Oct 20222:00 pmRNSPrice Monitoring Extension
13th Oct 202211:05 amRNSSecond Price Monitoring Extn
13th Oct 202211:00 amRNSPrice Monitoring Extension
12th Oct 20227:00 amRNSIssue of Equity
11th Oct 20227:00 amRNSFurther Funding and Funding Restructuring
5th Oct 20229:05 amRNSSecond Price Monitoring Extn
5th Oct 20229:00 amRNSPrice Monitoring Extension
5th Oct 20227:20 amRNSCompletion of sale
23rd Feb 20224:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:35 pmRNSPrice Monitoring Extension
28th Jan 20221:43 pmRNSInterim Results
4th Jan 20224:36 pmRNSHolding(s) in Company
29th Oct 20212:16 pmRNSFinal Results
7th Oct 202110:08 amRNSChange of Broker
4th Oct 20217:19 amRNSCompletion of Purchase of Energy Generation Sites
27th Sep 202110:44 amRNSHolding(s) in Company
15th Sep 20217:32 amRNSCompletion of Gas Peaking Funding
17th Aug 202110:55 amRNSHolding(s) in Company
10th Aug 202110:03 amRNSUpdate Re Funding
19th Jul 20217:00 amRNSHolding(s) in Company
19th Jul 20217:00 amRNSHolding(s) in Company
15th Jul 202111:19 amRNSResult of GM
30th Jun 20212:06 pmRNSSecond Price Monitoring Extn
30th Jun 20212:00 pmRNSPrice Monitoring Extension
29th Jun 20213:42 pmRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.